Newsletter | July 12, 2021

07.12.21 -- Not Your Typical Biopharma CFO

 
Sponsor
Articles
The Collective Benefits Of A Collaborative CFO
 

Terry Coelho, CFO, works as a team member, not just a finance manager, at BioDelivery Sciences.

Companies To Watch: NervGen Pharma
 

NervGen Pharma is going beyond preclinicals to human trials for a drug that could repair and regrow neurons.

Biopharma Innovators: The Challenges And Opportunities
 
Biopharma companies are predicted to provide 85% of drugs within a decade. Yet small and midsize biopharmas face the challenge of marketing their innovations in a context of uneven distribution of funding, geopolitical battles, and suboptimal supply chains.
Video
First-Time CEOs: Firsthand Tales Of The Good, The Bad, And The Ugly
 

Since the CEO position comes with such high expectations and stress, we thought it would be interesting to speak with three first-time CEOs to hear their tales of the good, the bad, and the ugly. In this executive virtual roundtable (EVR), perspectives are provided by Roger Crystal, CEO, Opiant Pharmaceuticals, Frank Lee, CEO, Forma Therapeutics, and Ivana Magovcevic-Liebisch, Ph.D., J.D., CEO, Vigil Neuroscience.

Ask The Board
Gallup Reported That Millennials Want A Workplace That Cares About Employees’ Wellbeing. How Will We Engage The Millennials To Carry On, Or Will They Be Able To Change Pharma Culture?
 

See the answer from Stephen Rapundalo, Ph.D., president and CEO of MichBio.

Web-Exclusive Content
New U.S. Legislation Creates Momentum For Biosimilars
 

Most biosimilars still only have shares below 50% in the U.S., which is far different than market shares in Europe. One major reason is a mistrust around biosimilars’ safety and efficacy. Congress has stepped in to address that issue through the Advancing Education on Biosimilars Act of 2021, with the goal of encouraging rapid uptake soon after biosimilars become commercially available.

July 2021 Digital Edition
 

Inside you will find more on:

  • Med Device To Drug Developer
  • Decentralized Clinical Trials
  • CEO Corner
  • Stealth Mode Strategies

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines
 

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.